Skip to content 
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio. more
| Time Frame | STE | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -2.69% | -2.71% | -0.82% |
| 1-Month Return | -7.47% | -0.76% | 0.37% |
| 3-Month Return | -9.32% | 2.74% | 13.84% |
| 6-Month Return | -21.45% | -4.22% | 9.27% |
| 1-Year Return | -15.41% | 12.55% | 24.35% |
| 3-Year Return | -5.57% | 12.31% | 70.9% |
| 5-Year Return | -2% | 18.99% | 76.33% |
| 10-Year Return | 198.44% | 111.1% | 260.42% |
| Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 4.22B | 4.54B | 5.14B | 5.46B | 5.94B | [{"date":"2022-03-31","value":71.15,"profit":true},{"date":"2023-03-31","value":76.42,"profit":true},{"date":"2024-03-31","value":86.57,"profit":true},{"date":"2025-03-31","value":91.97,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Cost of Revenue | 2.34B | 2.56B | 2.92B | 3.06B | 3.31B | [{"date":"2022-03-31","value":70.72,"profit":true},{"date":"2023-03-31","value":77.22,"profit":true},{"date":"2024-03-31","value":88.25,"profit":true},{"date":"2025-03-31","value":92.37,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Profit | 1.88B | 1.98B | 2.22B | 2.40B | 2.63B | [{"date":"2022-03-31","value":71.69,"profit":true},{"date":"2023-03-31","value":75.41,"profit":true},{"date":"2024-03-31","value":84.45,"profit":true},{"date":"2025-03-31","value":91.48,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Gross Margin | 44.59% | 43.66% | 43.17% | 44.01% | 44.25% | [{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":97.93,"profit":true},{"date":"2024-03-31","value":96.82,"profit":true},{"date":"2025-03-31","value":98.71,"profit":true},{"date":"2026-03-31","value":99.24,"profit":true}] |
| Operating Expenses | 1.41B | 1.19B | 1.38B | 1.54B | 1.52B | [{"date":"2022-03-31","value":91.48,"profit":true},{"date":"2023-03-31","value":77.44,"profit":true},{"date":"2024-03-31","value":89.97,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2026-03-31","value":99.26,"profit":true}] |
| Operating Income | 477.81M | 791.10M | 836.12M | 866.64M | 1.10B | [{"date":"2022-03-31","value":43.37,"profit":true},{"date":"2023-03-31","value":71.8,"profit":true},{"date":"2024-03-31","value":75.89,"profit":true},{"date":"2025-03-31","value":78.66,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (194.32M) | (221.67M) | (266.62M) | (148.29M) | (105.40M) | [{"date":"2022-03-31","value":-19432100000,"profit":false},{"date":"2023-03-31","value":-22167200000,"profit":false},{"date":"2024-03-31","value":-26661600000,"profit":false},{"date":"2025-03-31","value":-14829300000,"profit":false},{"date":"2026-03-31","value":-10540000000,"profit":false}] |
| Pre-Tax Income | 366.80M | 680.27M | 702.81M | 796.21M | 1.05B | [{"date":"2022-03-31","value":35.02,"profit":true},{"date":"2023-03-31","value":64.95,"profit":true},{"date":"2024-03-31","value":67.11,"profit":true},{"date":"2025-03-31","value":76.02,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income Taxes | 82.34M | 124.07M | 149.53M | 184.65M | 262.20M | [{"date":"2022-03-31","value":31.41,"profit":true},{"date":"2023-03-31","value":47.32,"profit":true},{"date":"2024-03-31","value":57.03,"profit":true},{"date":"2025-03-31","value":70.42,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income After Taxes | 284.46M | 556.20M | 553.28M | 611.56M | 785.10M | [{"date":"2022-03-31","value":36.23,"profit":true},{"date":"2023-03-31","value":70.84,"profit":true},{"date":"2024-03-31","value":70.47,"profit":true},{"date":"2025-03-31","value":77.9,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income From Continuous Operations | 242.87M | 105.81M | 553.28M | 611.56M | 785.10M | [{"date":"2022-03-31","value":30.93,"profit":true},{"date":"2023-03-31","value":13.48,"profit":true},{"date":"2024-03-31","value":70.47,"profit":true},{"date":"2025-03-31","value":77.9,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true}] |
| Net Income | 243.89M | 107.03M | 378.24M | 614.64M | 785.10M | [{"date":"2022-03-31","value":31.06,"profit":true},{"date":"2023-03-31","value":13.63,"profit":true},{"date":"2024-03-31","value":48.18,"profit":true},{"date":"2025-03-31","value":78.29,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
| EPS (Diluted) | 7.91 | 8.21 | 8.87 | 9.23 | 10.17 | [{"date":"2022-03-31","value":77.78,"profit":true},{"date":"2023-03-31","value":80.73,"profit":true},{"date":"2024-03-31","value":87.22,"profit":true},{"date":"2025-03-31","value":90.76,"profit":true},{"date":"2026-03-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| STE | |
|---|---|
| Cash Ratio | 0.38 |
| Current Ratio | 2.09 |
| Quick Ratio | 1.54 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| STE | |
|---|---|
| ROA (LTM) | 6.65% |
| ROE (LTM) | 11.37% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| STE | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.33 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.67 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| STE | |
|---|---|
| Trailing PE | 25.58 |
| Forward PE | 18.18 |
| P/S (TTM) | 3.33 |
| P/B | 2.75 |
| Price/FCF | 81 |
| EV/R | 3.60 |
| EV/Ebitda | 13.42 |
| PEG | 1.64 |
STERIS plc (STE) share price today is $200.22
Yes, Indians can buy shares of STERIS plc (STE) on Vested. To buy
Yes, you can purchase fractional shares of STERIS plc (STE) via the Vested app. You can start investing in STERIS plc (STE) with a minimum investment of $1.
You can invest in shares of STERIS plc (STE) via Vested in three simple steps:
The 52-week high price of STERIS plc (STE) is $267.96. The 52-week low price of STERIS plc (STE) is $194.56.
The price-to-earnings (P/E) ratio of STERIS plc (STE) is 25.5821
The price-to-book (P/B) ratio of STERIS plc (STE) is 2.75
The dividend yield of STERIS plc (STE) is 1.23%
The market capitalization of STERIS plc (STE) is $19.75B
The stock symbol (or ticker) of STERIS plc is STE
Consider the share price of STERIS plc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether STERIS plc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in STERIS plc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the STERIS plc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of STERIS plc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that STERIS plc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
